Related Experiment Videos
Effects of chronic uremia on bone
Scandinavian Journal of Urology and Nephrology
|January 1, 1982
Summary
In patients with chronic renal failure, alkaline phosphatase and parathyroid hormone levels best predicted bone complications. However, these markers could not predict the specific bone changes observed in non-hemodialysis cases.
Area of Science:
- Nephrology
- Bone Metabolism
- Pathology
Background:
- Chronic renal failure (CRF) significantly impacts bone health.
- Uremia, a complication of CRF, is associated with distinct bone pathologies.
- Understanding bone changes in non-hemodialysis CRF patients is crucial for management.
Purpose of the Study:
- To evaluate osteoclast activity and osteoid in non-hemodialyzed CRF patients.
- To determine the predictive value of laboratory markers for bone complications in CRF.
- To compare bone changes in non-hemodialyzed CRF patients with those undergoing hemodialysis.
Main Methods:
- Iliac crest bone biopsies were analyzed from 21 CRF patients not on hemodialysis.
- Osteoclast activity, active osteoid, and inactive osteoid were quantified.
- Laboratory markers including alkaline phosphatase and parathyroid hormone were assessed.
Main Results:
- Alkaline phosphatase and parathyroid hormone levels were the best predictors of bone complications in uremic patients.
- No single laboratory variable or combination could predict the specific type of bone changes.
- Osteoclast activity was lower compared to hemodialysis cases, suggesting reduced importance of secondary hyperparathyroidism.
Conclusions:
- Alkaline phosphatase and parathyroid hormone are key indicators for bone complications in non-hemodialyzed CRF.
- Predicting specific bone pathologies in CRF remains challenging despite laboratory markers.
- Secondary hyperparathyroidism may play a lesser role in bone disease for non-hemodialyzed CRF patients.